DRKS00025279招募中不适用
To determine the value of PET/MRI for diagnosis, therapy monitoring, and prognostic value in patients with spondyloarthritis before and after initiation of various drug therapies.
Rheumazentrum Ruhrgebiet0 个研究点目标入组 50 人开始时间: 2023年6月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Diagnosis of spondyloarthritis (radiographic or nonradiographic axial spondyloarthritis, or psoriatic arthritis with axial skeletal involvement).
- •Clinical indication for [18F]fluoride PET examination.
- •Clinical indication for initiation of drug therapy (TNF blocker, interleuking-17 blocker, Janus kinase inhibitor, NSAID.) for a period of at least one month.
排除标准
- •-Pregnancy
- •-Severe renal insufficiency
- •-Cardiac pacemaker
- •-Non-MR compatible foreign material
- •-Severe claustrophobia
- •-Known allergy to contrast media
- •-Inability to understand the patient information sheet
研究者
相似试验
招募中
不适用
Evaluation of the value of PET/MRI for diagnosis and treatment monitoring of patients with ankylosing Spondylitis before and after Treatment with a TNF-blockerM45.09DRKS00016917MSD Deutschland10
已完成
1 期
A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2MProstate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancerJPRN-UMIN000015356niversity of Tsukuba15
招募中
不适用
Feasibility study on the value of PET/MRI compared to PET/CT in oncological patients with a molecularly oriented individualized therapy conceptC00-C97Malignant neoplasmsDRKS00024032niversitätsklinikum Tübingen50
招募中
不适用
Application of PET-MR- a diagnostic accuracy study of combined dwMRI and 18F-Choline PET-CT for baseline staging of prostate cancer validated by extended laparoscopic lymph node dissection.100274761001818810038365prostate cancerNL-OMON39287Isala Klinieken45
进行中（未招募）
不适用
To determine the diagnostic accuracy of MRI in detecting lymph node metastases using USPIO (Ultra small super-paramagnetic iron oxide particles) in patients with gynecological malignancyEUCTR2004-002053-31-GBHammersmith Hospital100